As the nation marks National DNA Day on Sunday, April 25 — a day that commemorates the discovery of DNA’s double helix in 1953 and the completion of the Human Genome Project in 2003 — Mayo Clinic physicians and researchers will continue to closely collaborate to push the boundaries of precision medicine in the areas of cancer, rare and undiagnosed diseases, and predictive genomics.
Mayo Clinic has spent decades exploring and sequencing the human genome, allowing doctors to tailor a range of therapies to a patient’s genes. Now researchers in Mayo Clinic’s Center for Individualized Medicine will continue taking the achievement a step further ― beyond DNA ― and focusing on “multi-omics” data in their search for answers, including proteomics, the study of proteins in a cell; microbiome, the study of bacteria, fungi, protozoa and viruses that live inside the body; and metabolomics, the study of chemical processes to identify the underlying causes of diseases.
We asked five researchers within the Center for Individualized Medicine to reflect on the landmark achievements of DNA discovery and how it has affected their research and ability to precisely diagnose, treat and predict disease for patients.
Read the rest of the article on the Center for Individualized Medicine blog.
Other Mayo Clinic medical research websites: